Blood Res.  2015 Jun;50(2):73-79. 10.5045/br.2015.50.2.73.

Apoptosis: role in myeloid cell development

Affiliations
  • 1Stem Cells and Haematological Disorders Laboratory, Department of Biochemistry, School of Life Sciences, University of Hyderabad, Hyderabad, India. guttiravi@gmail.com
  • 2Department of Biotechnology, GITAM Institute of Science, GITAM University, Visakhapatnam, India.

Abstract

Hematopoiesis is the process that generates blood cells in an organism from the pluripotent stem cells. Hematopoietic stem cells are characterized by their ability to undergo self-renewal and differentiation. The self-renewing ability ensures that these pluripotent cells are not depleted from the bone marrow niche. A proper balance between cell death and cell survival is necessary to maintain a homeostatic condition, hence, apoptosis, or programmed cell death, is an essential step in hematopoiesis. Recent studies, however, have introduced a new aspect to this process, citing the significance of the apoptosis mediator, caspase, in cell development and differentiation. Extensive research has been carried out to study the possible role of caspases and other apoptosis related factors in the developmental processes. This review focuses on the various apoptotic factors involved in the development and differentiation of myeloid lineage cells: erythrocytes, megakaryocytes, and macrophages.

Keyword

Apoptosis; Caspase; Megakaryocyte; Erythrocyte; Monocyte; Differentiation

MeSH Terms

Apoptosis*
Blood Cells
Bone Marrow
Caspases
Cell Death
Cell Survival
Erythrocytes
Hematopoiesis
Hematopoietic Stem Cells
Macrophages
Megakaryocytes
Monocytes
Myeloid Cells*
Pluripotent Stem Cells
Caspases

Figure

  • Fig. 1 Extrinsic and intrinsic pathways of apoptosis. The extrinsic pathway is initiated by ligation of death receptors with death ligands. This interaction results in the formation of the death inducing signaling complex (DISC), which contains the death receptor, an adaptor molecule, and pro-caspase 8. Adaptor molecules possess a death domain (DD) and a death effector domain (DED). At the DISC, caspase 8 is autocatalytically activated and subsequently transmits the death signal to effector executioner caspases, resulting in apoptotic cell death. The intrinsic pathway signaling cascade is triggered by a number of factors, including DNA damage, hypoxia, growth factor deprivation, and ER stress. The death signal is sensed initially by the BH3-only protein, which then interacts with the downstream mediators of apoptosis (BAX and BAK). BAX and BAK undergo distinct conformational changes, which lead to the formation of mitochondrial pores or increases the permeability of the mitochondrial outer membrane, thereby releasing apoptogenic compounds, e.g. cytochrome c. Released cytochrome c binds to APAF-1 to facilitate formation of the apoptosome, a wheel-shaped heptameric complex, which can then recruit and activate pro-caspase 9. As a consequence, caspase 9 activates effector caspases (caspase 3, 6, or 7) and eventually leading to apoptosis. Abbreviations: TNF, tumor necrosis factor; TRAIL, TNF related apoptosis inducing ligand; FADD, Fas-associated death domain protein; TRADD, TNF receptor-associated death domain protein; BID, BH3 interacting-domain death agonist; tBID, truncated BID; BAX, Bcl-2 homologous antagonist/killer; BAK, Bcl-2 associated X protein; APAF-1, apoptotic protease activating factor-1.

  • Fig. 2 Major steps in hematopoiesis. Multiple caspases and apoptotic factors are involved in myeloid cell development. Apoptosis is a major mechanism utilized by the hematopoietic system to regulate blood cell production.


Reference

1. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972; 26:239–257. PMID: 4561027.
Article
2. Nicholson DW, Thornberry NA. Caspases: killer proteases. Trends Biochem Sci. 1997; 22:299–306. PMID: 9270303.
Article
3. Miura M, Zhu H, Rotello R, Hartwieg EA, Yuan J. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 1993; 75:653–660. PMID: 8242741.
4. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003; 22:8543–8567. PMID: 14634618.
Article
5. Yi CH, Yuan J. The Jekyll and Hyde functions of caspases. Dev Cell. 2009; 16:21–34. PMID: 19154716.
Article
6. Miura M. Active participation of cell death in development and organismal homeostasis. Dev Growth Differ. 2011; 53:125–136. PMID: 21338339.
Article
7. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci U S A. 1999; 96:10964–10967. PMID: 10500109.
Article
8. Nadiri A, Wolinski MK, Saleh M. The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis. J Immunol. 2006; 177:4239–4245. PMID: 16982854.
Article
9. Zermati Y, Garrido C, Amsellem S, et al. Caspase activation is required for terminal erythroid differentiation. J Exp Med. 2001; 193:247–254. PMID: 11208865.
Article
10. Allombert-Blaise C, Tamiji S, Mortier L, et al. Terminal differentiation of human epidermal keratinocytes involves mitochondria- and caspase-dependent cell death pathway. Cell Death Differ. 2003; 10:850–852. PMID: 12815468.
Article
11. Fernando P, Kelly JF, Balazsi K, Slack RS, Megeney LA. Caspase 3 activity is required for skeletal muscle differentiation. Proc Natl Acad Sci U S A. 2002; 99:11025–11030. PMID: 12177420.
Article
12. Wride MA. Lens fibre cell differentiation and organelle loss: many paths lead to clarity. Philos Trans R Soc Lond B Biol Sci. 2011; 366:1219–1233. PMID: 21402582.
Article
13. Sordet O, Rébé C, Plenchette S, et al. Specific involvement of caspases in the differentiation of monocytes into macrophages. Blood. 2002; 100:4446–4453. PMID: 12393560.
Article
14. Savill J, Fadok V. Corpse clearance defines the meaning of cell death. Nature. 2000; 407:784–788. PMID: 11048729.
Article
15. Bellone M, Iezzi G, Rovere P, et al. Processing of engulfed apoptotic bodies yields T cell epitopes. J Immunol. 1997; 159:5391–5399. PMID: 9548479.
16. Nagata S. Apoptosis by death factor. Cell. 1997; 88:355–365. PMID: 9039262.
Article
17. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001; 104:487–501. PMID: 11239407.
18. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science. 1998; 281:1305–1308. PMID: 9721089.
Article
19. Bhardwaj A, Aggarwal BB. Receptor-mediated choreography of life and death. J Clin Immunol. 2003; 23:317–332. PMID: 14601641.
20. Grell M, Wajant H, Zimmermann G, Scheurich P. The type 1 receptor (CD120a) is the high-affinity receptor for soluble tumor necrosis factor. Proc Natl Acad Sci U S A. 1998; 95:570–575. PMID: 9435233.
Article
21. Itoh N, Yonehara S, Ishii A, et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell. 1991; 66:233–243. PMID: 1713127.
Article
22. Walczak H, Degli-Esposti MA, Johnson RS, et al. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 1997; 16:5386–5397. PMID: 9311998.
Article
23. Tan KB, Harrop J, Reddy M, et al. Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells. Gene. 1997; 204:35–46. PMID: 9434163.
Article
24. Kischkel FC, Hellbardt S, Behrmann I, et al. Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 1995; 14:5579–5588. PMID: 8521815.
Article
25. Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004; 116:205–219. PMID: 14744432.
26. Wei MC, Zong WX, Cheng EH, et al. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science. 2001; 292:727–730. PMID: 11326099.
Article
27. Lomonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene. 2008; 27(Suppl 1):S2–S19. PMID: 19641503.
Article
28. Hockenbery D, Nuñez G, Milliman C, Schreiber RD, Korsmeyer SJ. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature. 1990; 348:334–336. PMID: 2250705.
Article
29. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC. Investigation of the subcellular distribution of the bcl-2 oncoprotein: residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res. 1993; 53:4701–4714. PMID: 8402648.
30. Nagata Y, Nagahisa H, Aida Y, Okutomi K, Nagasawa T, Todokoro K. Thrombopoietin induces megakaryocyte differentiation in hematopoietic progenitor FDC-P2 cells. J Biol Chem. 1995; 270:19673–19675. PMID: 7649975.
Article
31. Orkin SH, Zon LI. Hematopoiesis: an evolving paradigm for stem cell biology. Cell. 2008; 132:631–644. PMID: 18295580.
Article
32. Domen J, Cheshier SH, Weissman IL. The role of apoptosis in the regulation of hematopoietic stem cells: Overexpression of Bcl-2 increases both their number and repopulation potential. J Exp Med. 2000; 191:253–264. PMID: 10637270.
33. Bárcena A, Park SW, Banapour B, Muench MO, Mechetner E. Expression of Fas/CD95 and Bcl-2 by primitive hematopoietic progenitors freshly isolated from human fetal liver. Blood. 1996; 88:2013–2025. PMID: 8822920.
34. Nuñez G, Clarke MF. The Bcl-2 family of proteins: regulators of cell death and survival. Trends Cell Biol. 1994; 4:399–403. PMID: 14731816.
Article
35. Motoyama N, Kimura T, Takahashi T, Watanabe T, Nakano T. bcl-x prevents apoptotic cell death of both primitive and definitive erythrocytes at the end of maturation. J Exp Med. 1999; 189:1691–1698. PMID: 10359572.
Article
36. Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature. 2003; 426:671–676. PMID: 14668867.
Article
37. Gobbi G, Mirandola P, Carubbi C, et al. Phorbol ester-induced PKCepsilon down-modulation sensitizes AML cells to TRAIL-induced apoptosis and cell differentiation. Blood. 2009; 113:3080–3087. PMID: 18988868.
38. Gregory CJ, Eaves AC. Three stages of erythropoietic progenitor cell differentiation distinguished by a number of physical and biologic properties. Blood. 1978; 51:527–537. PMID: 623913.
Article
39. Rylski M, Welch JJ, Chen YY, et al. GATA-1-mediated proliferation arrest during erythroid maturation. Mol Cell Biol. 2003; 23:5031–5042. PMID: 12832487.
Article
40. Dolznig H, Habermann B, Stangl K, et al. Apoptosis protection by the Epo target Bcl-X(L) allows factor-independent differentiation of primary erythroblasts. Curr Biol. 2002; 12:1076–1085. PMID: 12121614.
Article
41. Silva M, Grillot D, Benito A, Richard C, Nuñez G, Fernéndez-Luna JL. Erythropoietin can promote erythroid progenitor survival by repressing apoptosis through Bcl-XL and Bcl-2. Blood. 1996; 88:1576–1582. PMID: 8781412.
Article
42. Gregoli PA, Bondurant MC. The roles of Bcl-X(L) and apopain in the control of erythropoiesis by erythropoietin. Blood. 1997; 90:630–640. PMID: 9226163.
Article
43. Gregory T, Yu C, Ma A, Orkin SH, Blobel GA, Weiss MJ. GATA-1 and erythropoietin cooperate to promote erythroid cell survival by regulating bcl-xL expression. Blood. 1999; 94:87–96. PMID: 10381501.
Article
44. Socolovsky M, Fallon AE, Wang S, Brugnara C, Lodish HF. Fetal anemia and apoptosis of red cell progenitors in Stat5a-/-5b-/- mice: a direct role for Stat5 in Bcl-X(L) induction. Cell. 1999; 98:181–191. PMID: 10428030.
45. Ribeil JA, Zermati Y, Vandekerckhove J, et al. Hsp70 regulates erythropoiesis by preventing caspase-3-mediated cleavage of GATA-1. Nature. 2007; 445:102–105. PMID: 17167422.
Article
46. Zeuner A, Eramo A, Testa U, et al. Control of erythroid cell production via caspase-mediated cleavage of transcription factor SCL/Tal-1. Cell Death Differ. 2003; 10:905–913. PMID: 12867998.
Article
47. Osada M, Komeno T, Todokoro K, et al. Immature megakaryocytes undergo apoptosis in the absence of thrombopoietin. Exp Hematol. 1999; 27:131–138. PMID: 9923451.
Article
48. Patel SR, Hartwig JH, Italiano JE Jr. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest. 2005; 115:3348–3354. PMID: 16322779.
Article
49. De Botton S, Sabri S, Daugas E, et al. Platelet formation is the consequence of caspase activation within megakaryocytes. Blood. 2002; 100:1310–1317. PMID: 12149212.
Article
50. Clarke MC, Savill J, Jones DB, Noble BS, Brown SB. Compart-mentalized megakaryocyte death generates functional platelets committed to caspase-independent death. J Cell Biol. 2003; 160:577–587. PMID: 12591916.
Article
51. Kozuma Y, Kojima H, Yuki S, Suzuki H, Nagasawa T. Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL. J Thromb Haemost. 2007; 5:1274–1282. PMID: 17389006.
Article
52. Acarin L, Villapol S, Faiz M, Rohn TT, Castellano B, González B. Caspase-3 activation in astrocytes following postnatal excitotoxic damage correlates with cytoskeletal remodeling but not with cell death or proliferation. Glia. 2007; 55:954–965. PMID: 17487878.
Article
53. Kozuma Y, Yuki S, Ninomiya H, Nagasawa T, Kojima H. Caspase activation is involved in early megakaryocyte differentiation but not in platelet production from megakaryocytes. Leukemia. 2009; 23:1080–1086. PMID: 19212331.
Article
54. Melloni E, Secchiero P, Celeghini C, et al. Functional expression of TRAIL and TRAIL-R2 during human megakaryocytic development. J Cell Physiol. 2005; 204:975–982. PMID: 15828026.
Article
55. Kozuma Y, Ninomiya H, Murata S, Kono T, Mukai HY, Kojima H. The pro-apoptotic BH3-only protein Bim regulates cell cycle progression of hematopoietic progenitors during megakaryopoiesis. J Thromb Haemost. 2010; 8:1088–1097. PMID: 20128868.
Article
56. White MJ, Schoenwaelder SM, Josefsson EC, et al. Caspase-9 mediates the apoptotic death of megakaryocytes and platelets, but is dispensable for their generation and function. Blood. 2012; 119:4283–4290. PMID: 22294729.
Article
57. Josefsson EC, Burnett DL, Lebois M, et al. Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways. Nat Commun. 2014; 5:3455. PMID: 24632563.
Article
58. Pagliari LJ, Perlman H, Liu H, Pope RM. Macrophages require constitutive NF-kappaB activation to maintain A1 expression and mitochondrial homeostasis. Mol Cell Biol. 2000; 20:8855–8865. PMID: 11073986.
59. Perlman H, Pagliari LJ, Georganas C, Mano T, Walsh K, Pope RM. FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med. 1999; 190:1679–1688. PMID: 10587358.
Article
60. Liu H, Perlman H, Pagliari LJ, Pope RM. Constitutively activated Akt-1 is vital for the survival of human monocyte-differentiated macrophages. Role of Mcl-1, independent of nuclear factor (NF)-kappaB, Bad, or caspase activation. J Exp Med. 2001; 194:113–126. PMID: 11457886.
61. Rébé C, Cathelin S, Launay S, et al. Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation. Blood. 2007; 109:1442–1450. PMID: 17047155.
Full Text Links
  • BR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr